112 related articles for article (PubMed ID: 14965777)
1. Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus.
Sun H; Luo H; Yu C; Sun T; Chen J; Peng S; Qin J; Shen J; Yang Y; Xie Y; Chen K; Wang Y; Shen X; Jiang H
Protein Expr Purif; 2003 Dec; 32(2):302-8. PubMed ID: 14965777
[TBL] [Abstract][Full Text] [Related]
2. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays.
Kuang WF; Chow LP; Wu MH; Hwang LH
Biochem Biophys Res Commun; 2005 Jun; 331(4):1554-9. PubMed ID: 15883050
[TBL] [Abstract][Full Text] [Related]
3. Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Chu LH; Choy WY; Tsai SN; Rao Z; Ngai SM
Protein Sci; 2006 Apr; 15(4):699-709. PubMed ID: 16600962
[TBL] [Abstract][Full Text] [Related]
4. Residues on the dimer interface of SARS coronavirus 3C-like protease: dimer stability characterization and enzyme catalytic activity analysis.
Chen S; Zhang J; Hu T; Chen K; Jiang H; Shen X
J Biochem; 2008 Apr; 143(4):525-36. PubMed ID: 18182387
[TBL] [Abstract][Full Text] [Related]
5. Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar-H+ ATPase G1 subunit.
Lin CW; Tsai FJ; Wan L; Lai CC; Lin KH; Hsieh TH; Shiu SY; Li JY
FEBS Lett; 2005 Nov; 579(27):6089-94. PubMed ID: 16226257
[TBL] [Abstract][Full Text] [Related]
6. In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putative cleavage site of coronavirus HKU1 3C-like protease.
Woo PC; Huang Y; Lau SK; Tsoi HW; Yuen KY
Microbiol Immunol; 2005; 49(10):899-908. PubMed ID: 16237267
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase.
Fan K; Wei P; Feng Q; Chen S; Huang C; Ma L; Lai B; Pei J; Liu Y; Chen J; Lai L
J Biol Chem; 2004 Jan; 279(3):1637-42. PubMed ID: 14561748
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique.
Chen S; Chen LL; Luo HB; Sun T; Chen J; Ye F; Cai JH; Shen JK; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Jan; 26(1):99-106. PubMed ID: 15659121
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
Pillaiyar T; Manickam M; Namasivayam V; Hayashi Y; Jung SH
J Med Chem; 2016 Jul; 59(14):6595-628. PubMed ID: 26878082
[TBL] [Abstract][Full Text] [Related]
10. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris.
Nguyen TT; Woo HJ; Kang HK; Nguyen VD; Kim YM; Kim DW; Ahn SA; Xia Y; Kim D
Biotechnol Lett; 2012 May; 34(5):831-8. PubMed ID: 22350287
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.
Muramatsu T; Takemoto C; Kim YT; Wang H; Nishii W; Terada T; Shirouzu M; Yokoyama S
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):12997-13002. PubMed ID: 27799534
[TBL] [Abstract][Full Text] [Related]
12. Autoprocessing: an essential step for expression and purification of enterovirus 71 3C(pro) in Escherichia coli.
Huang S; Lyu Y; Qing X; Wang W; Tang L; Cheng K; Wang W
Biotechnol Lett; 2013 Nov; 35(11):1845-52. PubMed ID: 23881322
[TBL] [Abstract][Full Text] [Related]
13. A novel auto-cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C-like protease.
Shan YF; Li SF; Xu GJ
Biochem Biophys Res Commun; 2004 Nov; 324(2):579-83. PubMed ID: 15474466
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis, purification, and characterization of the human coronavirus 229E 3C-like proteinase.
Ziebuhr J; Heusipp G; Siddell SG
J Virol; 1997 May; 71(5):3992-7. PubMed ID: 9094676
[TBL] [Abstract][Full Text] [Related]
15. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.
Shi J; Wei Z; Song J
J Biol Chem; 2004 Jun; 279(23):24765-73. PubMed ID: 15037623
[TBL] [Abstract][Full Text] [Related]
16. Engineering a novel endopeptidase based on SARS 3CL(pro).
Kuo CJ; Shih YP; Kan D; Liang PH
Biotechniques; 2009 Dec; 47(6):1029-32. PubMed ID: 20041855
[TBL] [Abstract][Full Text] [Related]
17. Characterization and inhibition of SARS-coronavirus main protease.
Liang PH
Curr Top Med Chem; 2006; 6(4):361-76. PubMed ID: 16611148
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.
Liu Z; Huang C; Fan K; Wei P; Chen H; Liu S; Pei J; Shi L; Li B; Yang K; Liu Y; Lai L
J Chem Inf Model; 2005; 45(1):10-17. PubMed ID: 15667124
[TBL] [Abstract][Full Text] [Related]
19. [Expression and activity analysis of Enterovirus 71 3C protease in Escherichia coli].
Chen L; Yang ZJ; Zhou Z; Cai WT; Teng XZ; Zhang GX
Bing Du Xue Bao; 2012 May; 28(3):195-200. PubMed ID: 22764519
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the active centre of coronavirus 3C-like proteases.
Hegyi A; Friebe A; Gorbalenya AE; Ziebuhr J
J Gen Virol; 2002 Mar; 83(Pt 3):581-593. PubMed ID: 11842253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
